covid-19 fda - Search News

Order byBest matchMost fresh

COVID-19, vaccine and FDA

Digest more

· 11h · on MSN

Here's what to know about the FDA's COVID-19 vaccine changes

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration.

· 3d · on MSN

FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups

· 2d

InnovationRx: FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk

MIT Technology Review · 16h

The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.

Covid vaccines will soon be required to go through more rigorous trials to ensure that they really are beneficial for people who aren’t at high risk.

Alaska Dispatch News · 15h

Opinion: The FDA’s new covid vaccine policy is clear as mud

· 1d

FDA panel recommends keeping COVID shots targeted to same strain as last year

· 1d

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 10h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 1d

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

8hon MSN

The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine access, and medical ethics.

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula,

1hon MSN

Phoenix doctor weighs in on possible limited access to COVID-19 shots

A Phoenix doctor weighs in on the potential impact of FDA plans to limit COVID booster access to high-risk groups, raising cost and care concerns.

1don MSN

FDA to limit COVID-19 boosters for 'low risk' people under 65. What to know in Tennessee

Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.

3don MSN

Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.

5don MSN

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe illness.

STAT1d

FDA asks mRNA vaccine makers to widen age range for rare heart risk warning

In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA vaccines to widen the age range of boys and young men that their labels say are at risk for a rare side effect causing heart inflammation.